Funding for this research was provided by:
Uniting Against Lung Cancer (2008)
National Cancer Institute (K01 CA76970)
American Cancer Society (IRG-67-003-44)
Received: 21 April 2020
Accepted: 23 July 2020
First Online: 8 August 2020
Ethics approval and consent to participate
: All animal experiment procedures were conducted in accordance with The Ohio State University Institutional Laboratory Animal Care and Use Committee and the regulations and guidelines of the institutional animal care and use committee (IACUC).
: Not applicable.
: M.A.V has received grant support for clinical trials from Merck Pharmaceutical Company. Other authors declare no conflict of interest.